We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
TACO is one of the most common causes of transfusion-related deaths in the UK and cases have increased substantially in recent years. Identifying risk factors for TACO prior to transfusion allows initiation of appropriate mitigating measures.
The symptoms and epidemiology of giardiasis including travel-associated infections.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Guidance for those affected by changes to UK immigration and borders due to coronavirus.
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
Application form to reduce the amount of water on an existing abstraction licence.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Advice and guidance on the health needs of migrant patients from Belarus for healthcare practitioners.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Information for patients, public and health care professionals.
How to prevent the introduction and spread of animal and bird disease by following good hygiene and biosecurity standards.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Argentina for healthcare practitioners.
Form L7 for the isolation, identification and toxin detection of clostridium botulinum and Staphylococcus aureus.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
Urgent public health message: UKHSA has been notified about an outbreak of food botulism in France involving a small number of British nationals.
Advice and guidance on the health needs of migrant patients from El Salvador for healthcare practitioners.
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.